GENIXUS
DEAD

Serial Number

90337589

Owner

Genixus, Corp.

Filing Date

Nov 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

GENIXUS Trademark

Serial Number: 90337589

GENIXUS is a trademark filed by Genixus, Corp. on November 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Genixus, Corp. (4 trademarks)

Kannapolis, NC 28081

Entity Type: 03

Trademark Details

Filing Date

November 23, 2020

Registration Date

Not Registered

Published for Opposition

December 28, 2021

Goods & Services

Contract manufacturing of pharmaceutical products; Contract manufacturing of pre-filled syringes containing pharmaceutical preparations; Manufacture, for others, of pharmaceutical and biopharmaceutical preparations

Pharmaceutical preparations and substances for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pre-filled syringes containing pharmaceutical preparations for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Injectable pharmaceuticals for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pre-filled syringes containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith

Pharmaceutical research services; Research and development of pharmaceutical products; Scientific research in the field of pharmacy; Scientific research into the development of new products, namely pharmaceutical preparations; Testing services for assessing the efficacy and safety of pharmaceuticals; Development of products, namely pharmaceutical preparations; Scientific and technological services in the field of pharmaceuticals and research and design relating thereto, namely, consulting and advisory services, CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; Industrial analysis and research services in the field of pharmaceuticals

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 25, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 25, 2024 ABN6
WITHDRAWAL OF ATTORNEY GRANTED
Feb 29, 2024 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Feb 29, 2024 WOAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 22, 2023 EXRA
SOU EXTENSION 3 GRANTED
Aug 18, 2023 EX3G
SOU EXTENSION 3 FILED
Aug 18, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 18, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 27, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jan 25, 2023 EX2G
SOU EXTENSION 2 FILED
Jan 25, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 25, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 13, 2022 EXRA
SOU EXTENSION 1 GRANTED
Aug 11, 2022 EX1G
SOU EXTENSION 1 FILED
Aug 11, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 11, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 22, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 28, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 28, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 8, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 13, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 12, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 13, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 13, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 13, 2021 CNRT
ASSIGNED TO EXAMINER
May 6, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2021 NWOS
NEW APPLICATION ENTERED
Nov 26, 2020 NWAP